La respuesta inicial al diltiazem tópico puede predecir la evolución de la fisura anal crónica

Lack of response to topical diltiazem 2% gel at the end of the first week reliably predicts failure of medical treatment for chronic anal fissure, obviating the need to prolong treatment for 8 weeks.